- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02621918
The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis (EESRDS)
July 25, 2016 updated by: Clara S C Rosa, Universidade Estadual Paulista Júlio de Mesquita Filho
The Effects of an Intradialytic Progressive Resistance and Aerobic Training in End-stage Renal Disease Patients Undergoing Hemodialysis
We aimed to investigate the effect of a progressive resistance training and aerobic training protocol on functional capacity, body composition and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Subjects were randomized into group A and B: group A (n=30) exercised for the first 6 months while group B (n=31) performed a placebo exercise initially (3 months) and cross-over to aerobic exercised for 3 months more.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- older than 18 years
- more than three months of hemodialysis vintage
- under the permission of their nephrologist
- agreement to be randomly assigned and undergo study protocols
Exclusion Criteria:
- Patients in wheelchair, presenting disability, or those who had amputation and malformation of the lower limbs, causing impaired walking
- presenting representative blindness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Progressive Resistance Training (PRT)
For the progressive resistance training we use 11 exercises.
The exercises for upper limbs were held in the waiting room before the hemodialysis session.
Resistance exercise was carried out in two sets of 15-20 repetitions, the intensity were determined by the method of maximal repetitions, where series were run until exhaustion to momentary exercises (15-20 repetitions) with specific load.
The load adjustments or volume were managed when necessary, but necessarily for every 4th week of training.
The effort perception should be situated between 12 and 16 on the Borg scale (Borg and Noble, 1974), as proposed by The Life Options Rehabilitation Advisory Council: Exercise for the Patient Dialysis (1995).
|
|
|
Experimental: Aerobic Exercise (AER)
Aerobic exercise was conducted with a mini ergometer cycling (Mini Bike E5 Acte Sports) attached to the patient chair.
Patients exercised 50-60 minutes of continuous workout with increased load.
The workload was adjusted when necessary, according to the perceived effort made by the patient.
The scale of perceived exertion, Borg scale (Borg and Noble , 1974), was used in accordance with the proposed By The Life Options Rehabilitation Advisory Council: Exercise for the Patient Dialysis (1995), which defines the values of perceived exertion between 12 and 16.
|
|
|
Placebo Comparator: NEPLA
The control group performed active mobilization of members, circumduction of cervical, scapular girdle and extremities, breathing exercises with no loads, set on three to five repetitions only and no stretch exercises.
The exercises were performed during the hemodialysis session, three times per week and did not exceed 5 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition by Dual-energy x-ray absorptiometry (DEXA)
Time Frame: before and after 12 and 24 weeks of study
|
Dual-energy x-ray absorptiometry (DEXA) was used to measure lean body mass (LBM), fat mass (FM) and Bone Mineral Contend (BMC) in grams using a total body scan, following the equipment description - HOLOGIC Discovery Wi (Hologic inc, Waltham, MA, USA).
Body composition variables included in this study were total mass, body FM, LBM and legs LBM, and BMC.
Body composition was assessed after a hemodialysis day; time after previous hemodialysis did not exceed eight hours.
|
before and after 12 and 24 weeks of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life assessed by the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36)
Time Frame: before and after 12 and 24 weeks of study
|
Quality of life assessment was analyzed using the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36).
The SF-36 is composed of eleven issues of 36 items that assess eight dimensions events occurred in the last four weeks.
For the presentation of the survey results, the final score of each domain was transformed into a scale from 0 (worse) to 100 (better).
Total score, mental e physical dimensions were analyzed separated.
|
before and after 12 and 24 weeks of study
|
|
Functional capacity
Time Frame: before and after 12 and 24 weeks of study
|
The 6 minutes walking test measured the walking capacity (distance in meters) during 6 minutes.
The sit-to-stand test assessed the lower limbs strength resistance by times that the subject stand and sit (chair) during 30 seconds.
And flexibility was assessed by sit and reach test.
|
before and after 12 and 24 weeks of study
|
|
Pulmonary capacity
Time Frame: before and after 12 and 24 weeks of study. Additionally this variable was assessed over the three time points before and after one hemodialysis session.
|
For the assessment of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) an analog manovacuometer (Gerar ®, 0±300 cmH2O) was used.
Patients underwent three valid maneuvers and the most negative and most positive in MIP and MEP, respectively, were considered.
Ventilometer (Ferraris Mark8 Wright Respirometer®) detected the low vital capacity (LVC).
Reduced forced expiratory volume in one second (FEV1), reduced forced vital capacity (FVC), normal FEV1/FVC ratio, and forced expiratory flow between 25% and 75% of vital capacity (FEF25-27) were evaluated with the spirometer brand IQTeQ.
Spirometric variables were analyzed in reference percentage values in order to eliminate the effects of age, height, and gender.
The assay was performed in order to obtain three acceptable curves with at least two reproducible curves five minutes interval for each exam for a total of up to eight trials.
|
before and after 12 and 24 weeks of study. Additionally this variable was assessed over the three time points before and after one hemodialysis session.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
October 21, 2015
First Submitted That Met QC Criteria
December 1, 2015
First Posted (Estimate)
December 4, 2015
Study Record Updates
Last Update Posted (Estimate)
July 27, 2016
Last Update Submitted That Met QC Criteria
July 25, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE-02564112.2.0000.5423
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Failure on Dialysis
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
-
Sir Mortimer B. Davis - Jewish General HospitalMcGill University Health Centre/Research Institute of the McGill University...Not yet recruitingEnd Stage Renal Disease on Dialysis
-
Chang Gung Memorial HospitalNot yet recruitingEnd Stage Renal Disease on Dialysis | Intradialytic HypotensionTaiwan
-
Tuen Mun HospitalEnrolling by invitationDialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis (DETECT-PD)Peritoneal Dialysis | End-Stage Kidney Disease | End Stage Renal Disease (ESRD) | End Stage Renal Failure on Dialysis | Peritoneal Dialysis Patients | End Stage Renal Disease on Dialysis (Diagnosis)Hong Kong
-
The University of Hong KongBaxter Healthcare CorporationCompleted
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd Stage Renal Failure on DialysisUnited States
-
Massachusetts General HospitalCompletedEnd Stage Renal Failure on DialysisUnited States
-
Palo Alto Veterans Institute for ResearchUnknownEnd Stage Renal Failure on DialysisUnited States
-
Praxisverbund Dialyse und AphereseCompletedEnd Stage Renal Failure on Dialysis
-
Hallym University Medical CenterWithdrawnEnd Stage Renal Failure on DialysisKorea, Republic of
Clinical Trials on Aerobic training
-
University of BarcelonaCompleted
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
Hadassah Medical OrganizationCompletedThe Influence of Different Training Regimens on Electrical Stability Following Myocardial InfarctionIschemic Heart Disease | Congestive Heart FailureIsrael
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtCompleted
-
Riphah International UniversityCompleted
-
Cardenal Herrera UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Duke UniversityCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany